MCRA Helps Noctrix Secure Authorization for RLS Therapy
MCRA LLC assisted Noctrix Health in obtaining FDA marketing authorization for the NTX100 Tonic Motor Activation System for patients with RLS.
Stay updated with breaking news from Motor Activation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MCRA LLC assisted Noctrix Health in obtaining FDA marketing authorization for the NTX100 Tonic Motor Activation System for patients with RLS.
/PRNewswire/ -- MCRA, LLC, a leading medical device focused regulatory advisory firm and clinical research organization (CRO) integrating U.S. and...
The FDA has granted Noctrix Health its de novo request for the NTX100 Tonic Motor Activation System, the first therapy for patients with moderate to severe, drug-refractory restless legs syndrome, according to a company press release.
The FDA has cleared the NTX100 Tonic Motor Activation System for the treatment of medication-refractory moderate to severe RLS.
/PRNewswire/ -- Noctrix Health announced that the U.S. Food and Drug Administration (FDA) has granted its De Novo request for the NTX100 Tonic Motor Activation...